Taylor, Adam

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Thiele, E. A., Marsh, E. D., French, J. A., Mazurkiewicz-Beldzinska, M., Benbadis, S. R., Joshi, C., Lyons, P. D., Taylor, A., Roberts, C., Sommerville, K., et al. (2018) · The Lancet

Epilepsy research and treatmentCannabis and Cannabinoid Research

Cited by 905

Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial

McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry

Cannabis and Cannabinoid ResearchSchizophrenia research and treatment

Cited by 617

Encoding of Time-Discounted Rewards in Orbitofrontal Cortex Is Independent of Value Representation

Roesch, M. R., Taylor, A. R., & Schoenbaum, G. (2006) · Neuron

Neural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 297

The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis

Woodcock, H. V., Eley, J. D., Guillotin, D., Platé, M., Nanthakumar, C. B., Martufi, M., Peace, S., Joberty, G., Poeckel, D., Good, R. B., et al. (2019) · Nature Communications

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPI3K/AKT/mTOR signaling in cancer

Cited by 224